Form D · Other

PHARMACA INTEGRATIVE PHARMACY INC

Boulder, CO · CIK 0001224940

Offering snapshot reported Feb 8, 2017 · SEC filing

Reported sold
$7M
Offering amount: $7M
Investors reported
14
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 31, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 8, 2017Initial$6,999,998No comparison14SEC filing
Aug 13, 2009Initial$6,555,000No comparison18SEC filing
May 19, 2009Initial$6,138,778No comparisonNot reportedSEC filing
Mar 24, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Oct 23, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-280259

Source: Form D, filed Feb 8, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Peter Cornetta Director
Martin Hanaka Director
Anya Hayden Director
Alan Kessock Executive
Michael Kruteck Executive
Joel Liffmann Director
David Maher Director
Janet Mathews Executive
Corey Mulloy Director
Mark Panzer Executive
Barry Perzow Director, Executive
William Rosenzweig Director
Gregory D. Scott Director
Greg Scott Director
Thomas Stemberg Director
Richard Willis Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
4940 Pearl East Circle, Suite 301
Boulder, CO, 80301